ClinicalTrials.gg
RecruitingNCT05961800OMEGAUpdated Jul 27, 2026

Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks

An interventional study of Cutaneous Probe and Quantitative Sensory Testing in Pain, Chronic, Facet Joint Pain and Pain, Procedural, sponsored by University of Pittsburgh. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study examines the relationship between central nervous system (CNS) mechanisms of pain inhibition and the pain relief that occurs following a lumbar medial branch block (MBB).

Read the detailed description

This study examines the relationship between central nervous system (CNS) mechanisms of pain inhibition and the pain relief that occurs following a commonly-performed nerve block used to diagnose and treat chronic low back pain. Patients scheduled for lumbar medial branch blocks as part of routine clinical care will arrive to clinic prior to the block for quantitative sensory testing procedures that measure CNS pain modulation. Patients will then undergo treatment as usual with their block, subsequently reporting low back pain intensity in a pain diary.

02

Conditions studied

  • Pain, Chronic
  • Facet Joint Pain
  • Pain, Procedural
  • Analgesia

Keywords

  • lumbar
  • medial branch block
  • offset analgesia
  • onset hyperalgesia
  • QST
  • quantitative sensory testing
03

In context

Chronic Pain

3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,419 studies on the registry; 168 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for lumbar MBB in UPMC Pain Management clinics
  • Age > 18 years old
  • Predominantly axial chronic low back pain at least 3 months on a daily basis
  • Must meet the minimum criteria for cognitive function using the PROMIS 2-item cognitive screener (>3)
  • Low back pain intensity of > 3/10
  • Willing and able to receive study-related phone calls

Exclusion criteria

Exclusion Criteria:

  • History of spine surgery at the level of the lumbar MBB
  • Active worker's compensation or litigation claims
  • New pain and/or psychiatric treatments within 2 weeks of enrollment
  • Not fluent in English and/or not able to complete the questionnaires
  • Any clinically unstable systemic illness that is judged to interfere with the study
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Quantitative Sensory Testing

    Participants with chronic low back pain and a scheduled lumbar medial branch block undergo quantitative sensory testing.

    Behavioral: Cutaneous Probe · Behavioral: Quantitative Sensory Testing · Behavioral: Computer Tasks

Interventions

  • BehavioralCutaneous Probe

    A computer-controlled probe delivers temperatures to the skin to measure pain, offset analgesia and onset hyperalgesia.

  • BehavioralQuantitative Sensory Testing

    Standard methods involving pinprick, pressure, heat, and cold applied to the skin are used to measure sensation and pain

  • BehavioralComputer Tasks

    Quantitative Sensory Testing (QST) and computer tasks are used to measure changes in pain intensity.

06

What researchers measure

Primary outcomes

  1. Offset analgesia and onset hyperalgesia

    Pain intensity difference during heat stimuli measured on a 0-100 sliding scale (0 is no pain, 100 is the most intense pain imaginable) at baseline

    Time frame: during this portion of the study visit (30 minutes)

  2. Low back pain intensity change

    Patients respond to the question "How would you rate your back pain right now?" from 0 (no pain) to 10 (worst imaginable pain) to see how intense their back pain is each hour after the lumbar medial branch block.

    Time frame: Immediately after lumbar medial branch block and up to 16 hours after lumbar medial branch block

Secondary outcomes

  1. Duration of low back pain

    Participant self-reports the number of years they have experienced low back pain. The number of years for each participant will be reported.

    Time frame: Baseline

  2. PEG: A Three-Item Scale Assessing Pain Intensity and Interference

    Assessment for self-reported average pain and pain interference within past 7 days. Responses range from 0 (no pain) to 10 (pain as bad as you can imagine). Total scores range from 0-30, and higher scores indicate more pain interference.

    Time frame: Baseline

  3. Baseline Back Pain Intensity

    Assessment for determining how much a person hurts with a question ranked on a 11-point scale, from "0 = no pain" to "10 = worst imaginable pain." The minimum raw summed score is 0 and the maximum score is 10. Lower raw response scores suggest lower pain intensity and better outcomes.

    Time frame: Baseline

  4. PROMIS Pain Interference 4a

    Assessment for self-reported consequences of pain with 4 questions ranked on a 5-point scale, from "not at all" to "very much". The minimum raw summed score is 4 and the maximum score is 20. Lower scores suggest better outcomes.

    Time frame: Baseline

  5. PROMIS Physical Function- 6b

    Assessment for self-reported capability with 6 qualitatively scaled questions ranked on a 5-point scale, from "without any difficulty" to "unable to do" or "not at all" to "cannot do." The minimum raw summed score is 6 and the maximum score is 30.

    Time frame: Baseline

  6. PROMIS Sleep Disturbance 6a

    Assessment for self-reported perceptions of sleep quality and sleep depth with 6 questions ranked on a 5-point scale. The minimum raw summed score is 6 and the maximum score is 30. Lower scores suggest better outcomes.

    Time frame: Baseline

  7. 6-item Pain Catastrophizing Scale

    Standardized survey score assessing pain perception before the study procedures begin. Rumination subscale score ranges from 0-16. Magnification subscale score ranges 0-12. Helplessness subscale score ranges from 0-24. Total score can be calculated by summing subscales. Total score ranges from 0-52, with higher scores indicating more pain catastrophizing.

    Time frame: Baseline

  8. Patient Health Questionnaire (PHQ-2)

    The PHQ-2 inquires about the frequency of depressed mood and anhedonia over the past two weeks. The PHQ-2 includes the first two items of the PHQ-9. A PHQ-2 score ranges from 0-6. The authors identified a score of 3 as the optimal cutpoint when using the PHQ-2 to screen for depression. If the score is 3 or greater, major depressive disorder is likely.

    Time frame: Baseline

  9. PROMIS 4-item Depression

    Assessment for self-reported negative mood and views of self with 4 questions ranked on a 5-point scale, from "never" to "always". The minimum raw summed score is 4 and the maximum score is 20. Lower t-scores suggest better outcomes.

    Time frame: Baseline

  10. PROMIS 4-item Anxiety

    Assessment for self-reported fear, anxious misery, hyperarousal, and somatic symptoms with 4 questions ranked on a 5-point scale, from "never" to "always". The minimum raw summed score is 4 and the maximum score is 20. Lower scores suggest better outcomes.

    Time frame: Baseline

  11. Areas of Pain Body Map

    The digital body figure contains 36 anterior regions and 38 posterior regions on which participants can mark areas in which they experience chronic pain. The number of pain areas each participant recorded will be reported, with a possibility of 74 total regions.

    Time frame: Baseline

  12. Treatment Expectancy

    Assessment for the subject's expectations of treatment effec prior to lumbar medial branch block. Scores range from 0 (not at all) to 4 (very much), with total scores ranging from 0-24. Higher scores indicate higher expectations of the low back pain treatement.

    Time frame: Baseline

  13. Patient Global Impression of Change

    The subject's impression of the impact of the lumbar medial branch block on their pain and function will be measured with a 7-item scale (1 = very much worse, 2 = much worse, 3 = minimally worse, 4 = no change, 5 = minimally improved, 6 = much improved, 7 = very much improved).

    Time frame: Immediately after lumbar medial branch block

  14. Situational pain catastrophizing scale (S-PCS)

    Standardized survey score assessing pain perception immediately following the lumbar medial branch block. Scores range from 0-24, with higher scores representing more pain catastrophizing.

    Time frame: Immediately after lumbar medial branch block

  15. Pain intensity during QST

    Changes in pain intensity during quantitative sensory tests measured on a 0-100 sliding scale (0 is no pain, 100 is the most intense pain imaginable)

    Time frame: during this portion of the study visit (60 minutes)

  16. Baseline back pain intensity

    Patients respond to the question "How would you rate your back pain on average?" from 0 (no pain) to 10 (worst imaginable pain) to see how intense their back pain is before the lumbar medial branch block.

    Time frame: baseline

  17. Back pain intensity after lumbar medial branch block

    Patients respond to the question "How would you rate your back pain right now?" from 0 (no pain) to 10 (worst imaginable pain) to see how intense their back pain is each hour after the lumbar medial branch block.

    Time frame: Immediately after lumbar medial branch block and up to 16 hours after lumbar medial branch block

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data will be available, including data dictionaries, after publication per journal and funding protocols. The statistical analysis plan and analytic code will also be available per the same protocols.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Data will become available after publication per journal and funding entity protocols.

Access criteria: Data will be made available by reasonable request and/or per journal and funding entity protocols.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05961800
Responsible party
Benedict Alter (Assistant Professor, University of Pittsburgh) — Principal investigator
First posted
Jul 27, 2023
Start date
Jul 5, 2023
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jul 27, 2026

Study contacts

Maya L Maurer, BS
Contact
mam708@pitt.edu
412-665-8052
Benedict J Alter, MD, PhD
Contact
alterbj@upmc.edu
412-677-0575
Benedict J Alter, MD, PhD
principal investigator · University of Pittsburgh

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion